School of Medicine


Showing 691-700 of 759 Results

  • Andre Kumar MD, MEd

    Andre Kumar MD, MEd

    Clinical Associate Professor, Medicine

    BioDr. Andre Kumar is a Clinical Associate Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD degree from Tulane University and completed his residency and chief residency in internal medicine at Stanford University, where he also earned a Master's in Education.

    As a passionate educator and researcher, Dr. Kumar has completed three randomized trials on POCUS and its impact on patient care. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. He is the lead investigator for a multicenter trial related to ultrasound and COVID-19. He was also an investigator for the ACTT and ACTIV trials for COVID-19, which brought the first COVID-19 therapeutics to patients nationwide. Currently, he is the Stanford Hospital lead for the National Institutes of Health RECOVER trial, a 1 billion dollar effort to understand the long-term effects of COVID-19 on patients.

    Dr. Kumar has held numerous leadership positions, including serving as President of the Society of Hospital Medicine (SHM) Bay Area, Director of the Stanford Internal Medicine Procedure Service, Director for the Rathmann Fellowship in Medical Education, Director of the Stanford Medicine Residency Hospitalist Training Track, Associate Course Director and Q4 Lead for Practice of Medicine, Co-Director of Clinical Reasoning, and Co-Director for Advanced Clinical Skills in the School of Medicine

    List of publications: https://bit.ly/3eop95i

    ClinicalTrials.Gov registration:
    https://bit.ly/2TizOmD
    https://bit.ly/2zeNBjJ

    Media:
    https://shorturl.at/rNU46
    https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
    https://bit.ly/33MZa0O
    https://bit.ly/3t8HE2u
    https://wb.md/2zfjY1N

  • Kevin K. Kumar, MD, PhD

    Kevin K. Kumar, MD, PhD

    Clinical Instructor, Neurosurgery

    BioDr. Kevin K. Kumar was born in New York City and grew up in Long Island, New York. He attended college at Cornell University where he majored in Biological Sciences with a concentration in Neurobiology and Behavior. After graduation, Dr. Kumar joined the Medical Scientist Training Program (MSTP) at Vanderbilt University to earn his combined MD/PhD. He completed his PhD in Neuroscience in the laboratory of Dr. Aaron Bowman, where he studied the regulation of manganese in both Parkinson’s and Huntington’s disease using high throughput screening, induced pluripotent stem cells, and untargeted metabolomics. He then began his neurosurgery residency at Stanford. As a resident, Dr. Kumar completed an NIH-funded postdoctoral fellowship in the laboratory of Dr. Marius Wernig in the Stanford Institute for Stem Cell Biology and Regenerative Medicine. His work focused on developing a platform to replace microglia in the brain as a novel therapy for neurodevelopmental disorders.

    From 2023-2024, Dr. Kumar will serve as Clinical Instructor in Pediatric Neurosurgery at Lucile Packard Children’s Hospital at Stanford. In addition to his clinical duties, he will continue to advance cellular therapeutics for pediatric neurological diseases.

  • Manoj Kumar

    Manoj Kumar

    Postdoctoral Scholar, Radiology

    Current Research and Scholarly InterestsI work on imaging-guided therapy using PET and MR imaging approaches. My academic training and background is in molecular imaging. During my doctoral training, I developed and validated a PET imaging approach for evaluating endocrine therapy responses in advanced breast cancer. My current research focuses on imaging tumor immune markers and responses to cancer immunotherapy. The goal is to develop new imaging toolboxes to monitor and guide treatment. Specifically, I employ antibodies, nanoparticles, and reporter genes for imaging and combinations of therapies to modulate and restore the body's suppressed immune functions against cancer cells. This is being done in collaboration with teams of researchers in early clinical development and teams in clinical practice.